Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration

Philip J. Rosenfeld, Steven D. Schwartz, Mark S. Blumenkranz, Joan W. Miller, Julia A. Haller, James D. Reimann, William L. Greene, Naveed Shams

Research output: Contribution to journalArticlepeer-review

208 Scopus citations

Fingerprint Dive into the research topics of 'Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration'. Together they form a unique fingerprint.

Medicine & Life Sciences